MicroPort CardioFlow Medtech Corporation (HKG:2160)

HKG:2160 Revenue

MicroPort CardioFlow Medtech had revenue of 229.10M CNY in the half year ending June 30, 2025, with 29.85% growth. This brings the company's revenue in the last twelve months to 367.53M, down -4.02% year-over-year. In the year 2024, MicroPort CardioFlow Medtech had annual revenue of 361.57M with 7.54% growth.

• Revenue (ttm): 367.53M CNY
• Revenue Growth: -4.02%
• P/S Ratio: 16.92
• Revenue / Employee: 854.72K CNY
• Employees: 430
• Market Cap: 6.81B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	361.57M	25.35M	7.54%
Dec 31, 2023	336.22M	85.19M	33.94%
Dec 31, 2022	251.03M	50.21M	25.00%
Dec 31, 2021	200.81M	96.88M	93.21%
Dec 31, 2020	103.93M	82.43M	383.37%